Increase in Fecal Primary Bile Acids and Dysbiosis in Patients with Diarrhea-predominant Irritable Bowel Syndrome
Overview
Neurology
Authors
Affiliations
Background: Irritable bowel syndrome (IBS) is a multifactorial disease for which a dysbiosis of the gut microbiota has been described. Bile acids (BA) could play a role as they are endogenous laxatives and are metabolized by gut microbiota. We compared fecal BA profiles and microbiota in healthy subjects (HS) and patients with diarrhea-predominant IBS (IBS-D), and we searched for an association with symptoms.
Methods: Clinical features and stool samples were collected in IBS-D patients and HS. Fecal BA profiles were generated using HPLC coupled to tandem mass spectrometry. The fecal microbiota composition was assessed by q-PCR targeting dominant bacterial groups and species implicated in BA transformation.
Key Results: Fourteen IBS-D patients and 18 HS were included. The two groups were comparable in terms of age and sex. The percentage of fecal primary BA was significantly higher in IBS-D patients than in HS, and it was significantly correlated with stool consistency and frequency. Fecal counts of all bacteria, lactobacillus, coccoides, leptum and Faecalibacterium prausnitzii were similar. There was a significant increase of Escherichia coli and a significant decrease of leptum and bifidobacterium in IBS-D patients.
Conclusions & Inferences: We report an increase of primary BA in the feces of IBS-D patients compared to HS, correlated with stool consistency and frequency. A dysbiosis of different bacterial groups was detected, some of them involved in BA transformation. As the gut microbiota is the exclusive pathway to transform primary into secondary BA, this suggests a functional consequence of dysbiosis, leading to lower BA transformation.
Uriot O, Deschamps C, Scanzi J, Brun M, Kerckhove N, Duale C Bioengineered. 2025; 16(1):2458362.
PMID: 39902883 PMC: 11796540. DOI: 10.1080/21655979.2025.2458362.
Iribarren C, Maasfeh L, Ohman L, Simren M Gut Microbiome (Camb). 2024; 3:e7.
PMID: 39295774 PMC: 11406401. DOI: 10.1017/gmb.2022.6.
Karhus M, Sonne D, Thomasen M, Ellegaard A, Holst J, Rehfeld J Gastro Hep Adv. 2024; 1(3):299-312.
PMID: 39131668 PMC: 11307667. DOI: 10.1016/j.gastha.2021.12.007.
Yang N, Ma T, Xie Y, Li Q, Li Y, Zheng L Nat Commun. 2024; 15(1):6823.
PMID: 39122704 PMC: 11315937. DOI: 10.1038/s41467-024-51094-2.
Gryaznova M, Smirnova Y, Burakova I, Morozova P, Lagutina S, Chizhkov P Microorganisms. 2024; 12(7).
PMID: 39065182 PMC: 11278693. DOI: 10.3390/microorganisms12071414.